 |
 |
|
Bio-Buzz No.06 / June 2007
IN THIS ISSUE HEADLINE NEWS
HEADLINE NEWS BioApproaches SW – A new manager We would like to take this opportunity to welcome Dr Pauline Lee as BioApproaches SW new manager: Pauline Lee Pauline has also been a researcher at the University of Nottingham where she worked in the Tissue Engineering Group on bio-artificial liver design. From there she moved to Yorkshire Forward, the regional development agency for Yorkshire & Humberside where she developed a strategy for informed investment to support the medical device, pharmaceutical and nutraceutical industries in the region.
INDUSTRY CORNER Funding New Diploma helps NHS organisations to exploit latent innovations and talent NHS Innovations South West (NISW), in partnership with Pera, have developed a completely new 'innovation and intellectual property exploitation’ service model. It differs from other models within the NHS on the basis that it focuses on embedding knowledge and skills in key individuals working within the NHS Trusts, who will manage and lead the innovation process on a local basis. The Trust Innovation Leadership programme was created as the key enabler for this new initiative and the core objectives of the programme focused on the development of professionally trained and accredited Trust Based Innovation Leaders (TILS) who are now capable of: driving innovation within their Trusts, stimulating a positive culture for change, managing the innovation process on a local level, realising the innovative potential that exists within the South West NHS. International Business Opportunities South West Innovation Relay Centre (SWIRC) 2. A Spanish spin-off company from Universidad Autónoma de Madrid has developed a rapid kit for assessing Sperm DNA Fragmentation & infertility in a large number of animal species. The company exploits the advantages of the test, according to a patented methodology. They are looking for a company or research centre working on animal health, which may be interested in a technical cooperation for the development of new kits for different animal species. They would also welcome commercial agreement. More HERE (pdf 121k) 3. A Spanish biotechnology company specialized in the use of the zebra fish as an animal model for biomedical and toxicological research, has developed and validated a Teratogenicity Assay with zebra fish embryos. The test can be used to detect teratogen compounds in 48 hrs. It is rapid, reliable and low cost. It is useful for biopharmaceutical companies, as a means to assess teratogenicity of lead compounds in secondary screening assays. The company is looking for technical cooperation agreements. More HERE (pdf 145k) 4. A Spanish company devoted to the diagnostic issue, has developed an improved Sperm Chromatin Dispersion (SCD) test that discriminates different levels of DNA fragmentation. The company is looking for partners interested in bringing the technology onto the market under a licensing agreement. More HERE (pdf 130k) 5. A Spanish spin-off has developed a platform to express recombinant proteins in plants. The main advantage of the technology is that it is based on non conventional transgenesis and offers a high biosafe profile. The company is looking for technical co-operation and manufacturing agreements with other companies or research institutes. More HERE (pdf 118k) 6. A Spanish company devoted to the diagnostic issue, has developed a kit which allows the study of the 46C/T polymorphism of the Factor XII gene. The company is looking for partners interested in bringing the technology onto the market under a licensing agreement. More HERE (pdf 117k) 7. A Spanish biotechnology company with already on-the-market technology able to express recombinant proteins in non-transgenic plants is seeking for a company or research institute that can provide new tools (expression vectors, technology, new enzymes or proteins of industrial interest) to incorporate to their technology portfolio. Technology can be close to the market or need some R&D. The company is looking for R&D, license and commercial agreements with technical assistance. More HERE (pdf 118k) 8. A Spanish company devoted to the diagnostic issue, is on the process to develop markers for early diagnosis of Alzheimer's disease. The company is looking for partners interested in bringing the technology onto the market under a licensing agreement. More HERE (pdf 117k) 9. A Spanish Biotechnology company, with already working technology able to express recombinant proteins in non-transgenic plants, is seeking for a company or research institute which can provide an antibody or antibody fragment with therapeutic applications. By a technical cooperation, license agreement or joint venture agreement, the Spanish company would clone and produce the antibody in their plant system and participate in further R&D, pilot and clinical studies. More HERE (pdf 117k) 10. A Spanish bioinformatics company offers state of-the-art software solutions for genomics, proteomics and drug discovery in 2 strategic areas: data management & integration, and intelligent data analysis and data mining. The company is looking for license and commercial agreements and technical co-operations. More HERE (pdf 118k) Contact Chris Pinnell for more information Chris.Pinnell@southwestrda.org.uk Training Support New Website on Careers in Biomedical Research Here The Academy of Medical Sciences has launched a new website on careers in biomedical research. It is designed to act as a portal for information, links and career opportunities for undergraduates, postgraduates, postdoc researchers.The website includes: Case studies and tips on how to progress your career Interviews with top scientists discussing their career paths and choices Information on training and funding opportunities contact Evolution for your free DIY Guide summary on how to conduct a Bioscience IP Valuation - T: 01355 272245 F: 01355 272246 W: www.evolutionlifescience.com Evolution has considerable experience in Bioscience IP valuation through a bespoke 'market approach'. The benefit to Universities is prioritization of funds to maximize commercialization potential of Bioscience technology, allowing a cost-effective decision on 'route to market'. Available free downloads:- . DIY GuideT to Bioscience IP Valuation . DIY GuideT to Licensing Biotech Patents . DIY GuideT to Licensing University Technology . DIY GuideT to Market Research Please contact Michelle Phinn HERE for free PDF documents. BIA Whistle-Stop Tour of Biotechnology, A Layperson's guide. NEW DATE: Tuesday 17th July 2007 BOOK NOW HERE Business opportunities Emerging Technologies Network Agency (ETNA) UK Funded Events 2006/07 - For more information on the trade missions below contact samantha.bruce@emtechna.netETNA are organising UK Pavilions at the following Trade Fairs in 2006 with government support for eligible companies. Please note all our shows are marked as "high tech" by UK Trade & Investment meaning that even if you are not a new exporter if you have not exhibited at this show in recent years you could still be eligible for a grant - assuming you are an SME. - Biotech Forum (24th-26th September, Stockholm) - 5,767 visitors found their way to Biotech Forum + Scanlab at Bella Centre for Biotech Forum & Scanlab 2006 in Copenhagen last September. This year sees the show back in Stockholm with a greater focus on the partnering aspect than in previous years. For the third consecutive year, ETNA will be taking a group to Biotech Forum. A stand on the UK Pavilion at Biotech Forum 2007 will cost £1,800 - with grants of £1,800 being available to eligible SMEs meaning the stand would actually not cost you anything!! - CPhI Worldwide (2nd-4th October, Milan) - ETNA have three companies signed up to a pavilion at CPhI Worldwide. - Biotechnica (9th-11th October, Hannover) - A pavilion with space for 8 companies has been booked at Biotechnica - half the space is already sold, with stands costing £2,600. Grants of £1,800 are available to eligible SMEs - AusBiotech (21st-24th October, Brisbane) - More information will be available shortly but in the meantime please contact Samantha to register your interest. MEDILINK East Midlands In September 2007 a delegation of 9 Healthcare companies from Eastern Germany are visiting the UK. The mission, supported by the German Ministry of Economics and Technology aims to intensify trade relation between SME’s from Eastern Germany and the UK. If you like the opportunity to meet with these companies during their visit, please contact Julia.farre@enterprise.plc.uk. UK Trade & Investment is considering inviting 6 key contacts from Japanese pharmaceutical companies to visit the UK and meet companies who are focused on working in platform/enabling technologies in November 2007. If you are interested in meeting this group, would you please send an expression of interest to Mina Joshi by June 30th. ZONAL EXHIBITOR PROPOSAL FOR GENESIS Conference 2007, Thursday 13th Dec 2007, London, please see HERE Genesis, London Biotechnology Network’s annual conference, now in its seventh year, is a well established industry event which last year saw a record 820+ delegates for the event that now includes the only UK Biotechnology Company Showcase delivered with UK Trade & Investment. A new element for the exhibition hall will include zones by therapeutic and/or technology areas offering biotech companies a cheaper, less time consuming means to attract potential partners and investors: Cost £295 + VAT to include full 2-day conference pass (normally £395) as well as: 1. An A1 portrait sized display board (scaleable to more than 1 if desired) 2. Pre-event promotion as part of the chosen zone 3. Delegate booklet company profile 4. Private investor, pharma and biotech pre-view session ahead of the main exhibition hall opening 5. No set times when the poster must be attended by the exhibiting company, but a facility for delegates to deposit business cards if they wish to follow up. We will also request that a photograph of the key contact be on the poster to aid potential delegates in finding them in the event. 
EVENTS LISTINGS Covering Lifesciences (biotechnology) and Medical interests can be found at HERE
Contact Us For further information on any of these items, please visit our website: Jade Fulbrook-Smith – Project Coordinator, BioBuzz Editor Gugs Lushai – Director of Network
|
|||
|
